D&D Pharmatech Inc. (347850)
Market Closed
11 Aug, 06:30
KRX SM KRX SM Primary ₩
60,900. 00
-4,800
-7.3059%
₩
- Market Cap
- P/E Ratio
- Div Yield
1.94M Volume
- Eps
₩ 65,700
Previous Close Want to track 347850 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
D&D Pharmatech Inc. (347850) Statistics
Valuation metrics
Market Cap -
Enterprise value 2.5T
Trailing P/E (ttm) -104.76
Forward P/E -
PEG ratio -3.86
Price/Sales (ttm) 835.98
Price/Book (mrq) 33.65
Enterprise Value/Revenue 829.81
Enterprise Value/EBITDA -127.03
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 2.26M
Average volume (90 days) 1.61M
Price summary
52-Week low 45,000
52-Week high 342,500
Beta -
50-Day moving average 73,572.86
200-Day moving average 79,204.81
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 4:1
Last split Date 13 Nov 2025
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -7.7%
Operating margin -11.88%
Operational effectiveness
Return on assets -0.25%
Return on equity -0.3%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 69.08
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -531.93
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 563.4
Total debt (mrq) -
Total Debt/Equity (mrq) 0.08
Current ratio (mrq) 8.02%
Book value per share (mrq) 1,695.49
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
